Tenofovir alafenamide for hepatitis B: evolution or revolution?

Lancet Gastroenterol Hepatol. 2016 Nov;1(3):174-175. doi: 10.1016/S2468-1253(16)30083-8. Epub 2016 Sep 22.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anti-HIV Agents
  • Antiviral Agents
  • HIV Infections
  • Hepatitis B*
  • Hepatitis B, Chronic
  • Humans
  • Tenofovir*

Substances

  • Anti-HIV Agents
  • Antiviral Agents
  • Tenofovir